Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, representing an incremental update to the page's documentation/configuration. No study content, eligibility criteria, or results are affected by this change.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedUpdated the ClinicalTrials.gov page revision/version indicator from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Gorlin syndrome as a related term and included the Genetic and Rare Diseases Information Center as a new resources link.SummaryDifference0.2%

- Check68 days agoChange DetectedSite revision updated to version 3.5.0 and previous version 3.4.3 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page revision label changed from v3.4.2 to v3.4.3, indicating a system update. No substantive study information or eligibility details were altered.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.